Access
To read this story in full you will need to login or make a payment (see right).
Commentary
Nature 455, 730-731 (9 October 2008) | doi:10.1038/455730a; Published online 8 October 2008
Open Innovation Challenges
-
Methods to Analyze Consumer Emotions
The Seeker is looking for methods to analyze consumer emotions. This Challenge requires only a writ...
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
- More Challenges
- Powered by:
nature jobs
Flash Animator
- Indegene Lifesystems Pvt. Ltd
- Bengaluru 560 071 India
Bioprocess Engineer
- Praj Matrix - Praj Industries Ltd
- Pune, Maharashtra Pune-411021 India
A network solution
Adriano Henney1 & Giulio Superti-Furga2
- Adriano Henney is a director of Global Discovery Enabling Capabilities and Sciences at AstraZeneca, Alderley Park, UK.
Email: adriano.henney@btinternet.com - Giulio Superti-Furga directs the Center for Molecular Medicine of the Austrian Academy of Sciences in Vienna, Austria.
Email: gsuperti@cemm.oeaw.ac.at
Abstract
With the right plan, systems biology can empower drug discovery, say Adriano Henney and Giulio Superti-Furga. Field leaders have contributed and now the authors want to hear from you.
Systems biology focuses on interactions within and between the mechanisms that combine to give rise to the function and behaviour of a biological system. To some it is the logical and inevitable next-level understanding that will propel drug discovery from empiricism to mechanism-based rational design.
To read this story in full you will need to login or make a payment (see right).
